Evidence Hub

Track evidence momentum and emerging diabetes research intelligence. Monitor relationship strength changes, identify accelerating evidence, and explore validated research insights.

Early access — Evidence base actively growing

Last updated: 6/10/2026

📚
83
Research Documents
🔗
457
Evidence Pairs
💊
105
Interventions
🎯
171
Outcomes
📂
7
Intervention Categories (L1)
📊
7
Outcome Categories (L1)
➡️

Featured Evidence Shift

Semaglutide → Body weight

Strongest evidence in the database

This relationship has 2 studies with moderate evidence, representing the most robust finding in our evidence base.

📌 Temporal tracking activates with monthly snapshots

Evidence Intelligence Snapshot

View all insights →

Strongest Evidence Relationship

Semaglutide → Body weight

60 Evidence Score
Explore evidence →

Research Documents Analyzed

Peer-reviewed studies in evidence base

83 peer-reviewed studies analyzed

Strong Evidence Areas

Relationships with strong or very strong ratings

0 – No strong evidence areas yet
No evidence available

Most Consistent Finding

Highest consistency score observed

100% consistency

Evidence Pairs Analyzed

Intervention-outcome combinations

457 evidence relationships analyzed

Most Studied Relationship

Highest research volume observed

5 studies on single relationship

Browse Evidence Topics

Explore evidence organized into clinically meaningful topics.

Clinical Outcomes

2

Evidence topics

Explore topics

Glycemic Control

2

Evidence topics

Explore topics

Medications

1

Evidence topic

Explore topics

Metabolic Health

2

Evidence topics

Explore topics

Weight & Anthropometrics

1

Evidence topic

Explore topics
📊

Temporal Intelligence Coming Soon

Evidence trends, state changes, and momentum history will activate once monthly snapshots accumulate. Requires at least two monthly evidence snapshots. Temporal intelligence will activate once historical data accumulates.

🛡️

Most Validated Relationships

Intervention-outcome relationships with the strongest evidence validation and replication

RelationshipEvidence StrengthStudiesConsistencyActions
Semaglutide → Body weight
moderate2consistent
Dapagliflozin → Renal and urinary disorders incidence
limited1(Single study)unclear
Liraglutide → HbA1c
limited1(Single study)unclear
Pioglitazone → Fasting Plasma Glucose
limited1(Single study)unclear
Pioglitazone → Triglycerides
limited1(Single study)unclear
Semaglutide → BMI
limited1(Single study)unclear

Scroll horizontally to see all columns

Evidence Collections

Curated collections of evidence organized by strength, topic, and clinical relevance

📋

Browse by Category

All major intervention and outcome categories in one place

CategoryTypeInterventions / OutcomesEvidence PairsStrongest EvidenceView
Physical Activityintervention3253LimitedView category →
Supplementsintervention3260LimitedView category →
Medicationsintervention65155ModerateView category →
Behavioral & Lifestyleintervention64109LimitedView category →
Diet and Nutritionintervention2242LimitedView category →
Devices & Technologyintervention2437LimitedView category →
Proceduresintervention11WeakView category →
Glycemic Controloutcome63157LimitedView category →
Metabolic Healthoutcome35107LimitedView category →
Weight & Anthropometricsoutcome3054ModerateView category →
Adherence & Engagementoutcome1419LimitedView category →
Patient Reportedoutcome1428LimitedView category →
Safetyoutcome2940LimitedView category →
Clinical Outcomesoutcome2252LimitedView category →